Diagnostic challenge in veterinary pathology: Pruritus in a dog with a mixed cellular infiltrate
Sign Up to like & getrecommendations! Published in 2022 at "Veterinary Pathology"
DOI: 10.1177/03009858221143401
Abstract: An 11-year-old, castrated male German Shepherd dog initially presented with a 9-month history of pruritus and multifocal erythematous skin lesions, alopecia, and mild weight loss. Skin lesions waxed and waned without complete resolution and newer… read more here.
Keywords: diagnostic challenge; veterinary pathology; pathology; pruritus ... See more keywords
Costs and cost-effectiveness of management of possible serious bacterial infections in young infants in outpatient settings when referral to a hospital was not possible: Results from randomized trials in Africa
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0247977
Abstract: Introduction Serious bacterial neonatal infections are a major cause of global neonatal mortality. While hospitalized treatment is recommended, families cannot access inpatient treatment in low resource settings. Two parallel randomized control trials were conducted at… read more here.
Keywords: serious bacterial; treatment; daily days; injection ... See more keywords
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27238589
Abstract: Doxorubicin (DOXO) is an antineoplastic drug that is used extensively in managing multiple cancer types. However, DOXO-induced cardiotoxicity is a limiting factor for its widespread use and considerably affects patients’ quality of life. Farnesol (FSN)… read more here.
Keywords: doxorubicin; cardiotoxicity; group; wistar rats ... See more keywords